G K Surdhar - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Methods in Molecular Medicine|February 23, 2011

Use of Intron 40 VNTR I in vWD Gene TrackingM S Enayat, G K Surdhar

Thrombosis and Haemostasis|October 6, 2000

A new candidate missense mutation (Leu 1657 IIe) in an apparently asymptomatic type 2A (phenotype IIA) von Willebrand disease familyM S Enayat, A M Guilliatt, G K Surdhar, et al.

Blood|July 27, 2001

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand diseaseM S Enayat, A M Guilliatt, G K Surdhar, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Methods in Molecular Medicine|February 23, 2011

Use of Intron 40 VNTR I in vWD Gene TrackingM S Enayat, G K Surdhar

Thrombosis and Haemostasis|October 6, 2000

A new candidate missense mutation (Leu 1657 IIe) in an apparently asymptomatic type 2A (phenotype IIA) von Willebrand disease familyM S Enayat, A M Guilliatt, G K Surdhar, et al.

Blood|July 27, 2001

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand diseaseM S Enayat, A M Guilliatt, G K Surdhar, et al.

Pageof 1